Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines
In short
This is a Pre-Commercial Procurement call under Horizon Europe. The budget is €26 million for about 3 grants of €8 million to €10 million each. Submission opens on 10 February 2027. Deadline: 16 September 2027.
What the call wants to achieve
- Public procurers, possibly in cooperation with private ones, in the area of cancer-centred healthcare stimulate the competitive development of market-ready, affordable, innovative solutions.
- The chosen solutions take into consideration the needs of cancer patients living with and beyond cancer through research that supports end-user engagement using participative research models.
- Procurers create opportunities for European health, technology and medical devices, industrial actors (including start-ups, spin-offs, spin-outs, scale-ups, SMEs) to bring to the market affordable innovations that are cost-efficient, safe and have demonstrated improved health outcomes for cancer patients living with (…)
- Procurers facilitate the commercialisation of innovative solutions for and with cancer patients by their successful suppliers through providing them with first customer references for the validation and first pilot deployment.
Source: EU Funding & Tenders Portal, © European Union, CC BY 4.0, summarised. The official call text and its annexes decide eligibility, budget and deadlines.
Similar calls
16 Septin 317 days
Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers
Opens 10 Feb
16 Septin 317 days
Support a Young Cancer Survivor Quality of Life (QoL) research programme by cancer charities and funding agencies
Opens 10 Feb
16 Septin 317 days
Leveraging functional genomics to reveal novel targets for cancer treatment
Opens 10 Feb
16 Septin 317 days
Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
Opens 10 Feb
16 Septin 317 days
Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research
Opens 10 Feb